Incidence and risk factors of severe adverse events with nevirapine-based antiretroviral therapy in HIV-infected women. MTCT-Plus program, Abidjan, Côte d'Ivoire

<p>Abstract</p> <p>Background</p> <p>In resource-limited settings where nevirapine-containing regimen is the preferred regimen in women, data on severe adverse events (SAEs) according to CD4 cell count are limited. We estimated the incidence of SAEs according to CD4 cell count and identify their ris...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Amani-Bosse Clarisse, Tanon Aristophane K, Tonwe-Gold Besigin, Coffie Patrick A, Bédikou Gédéon, Abrams Elaine J, Dabis François, Ekouevi Didier K
Format:	Artigo
Sprog:	Inglês
Udgivet:	BMC 2010-06-01
Serier:	BMC Infectious Diseases
Online adgang:	http://www.biomedcentral.com/1471-2334/10/188
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!